1. Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis
- Author
-
Fang-ping Xiao, Hao He, Meng Liu, Hai-bo Zhou, Lin Kuai, Mei Hong, Ming-yue Chen, and Zhi-qiang Jia
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Article ,Internal medicine ,Epidemiology ,Humans ,Medicine ,In patient ,Hospital Mortality ,Mortality ,business.industry ,COVID-19 ,Atrial fibrillation ,General Medicine ,Odds ratio ,medicine.disease ,Respiration, Artificial ,Confidence interval ,Survival Rate ,Meta-analysis ,Pneumonia ,Emergency Medicine ,business ,Arrhythmia - Abstract
Background Recently, emerging evidence has suggested that atrial fibrillation (AF) has an epidemiological correlation with coronavirus disease 2019 (COVID-19). However, the clinical outcomes of AF in COVID-19 remain inconsistent and inconclusive. The aim of this study was to provide a comprehensive description of the impact of AF on the prognosis of patients with COVID-19 pneumonia. Methods Three electronic databases (PubMed, Embase, and Web of Science) were searched for eligible studies as of March 1, 2021. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the associations between AF (preexisting and new-onset) and in-hospital mortality, post-discharge mortality, and ventilator use. Results A total of 36 individual studies were incorporated into our meta-analysis. The combined results revealed that preexisting AF was associated with increased in-hospital mortality (pooled OR: 2.07; 95% CI: 1.60–2.67; p
- Published
- 2021